Skip to main content
Signal8
Launch Terminal

INNOCAN PHARMA Corp (INNPF)

InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems by integrating cannabidiol (CBD) with diverse pharmaceutical ingredients. Its operations extend across the United States, Poland, France, and other international markets. The company actively pursues research and development into CBD-loaded exosomes for treating conditions like COVID-19, as well as advancing CBD-infused liposomes. InnoCan Pharma also commercializes a range of branded CBD-integrated pharmaceutical and topical treatment products, such as CBD eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Established in 2018, the corporation is headquartered in Calgary, Canada.

Sector: Pharmaceutical Preparations

Industry: Medical - Pharmaceuticals

InnoCan Pharma Corporation logo

InnoCan Pharma Corporation

OTC:INNPFHealthcare
-0.77%$1.29
Mkt Cap-
Float3.58M
O/S-
Inst Own-
Dilution
InnoCan Pharma Corporation logoOTC:INNPF$1.29-0.77%
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
SectorHealthcare
IndustryMedical - Pharmaceuticals
ExchangeOTC
CountryCACA
IPO Date-
Shares Outstanding-
Float3.58M
Company Overview

InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems by integrating cannabidiol (CBD) with diverse pharmaceutical ingredients.

Its operations extend across the United States, Poland, France, and other international markets.

The company actively pursues research and development into CBD-loaded exosomes for treating conditions like COVID-19, as well as advancing CBD-infused liposomes. InnoCan Pharma also commercializes a range of branded CBD-integrated pharmaceutical and topical treatment products, such as CBD eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Established in 2018, the corporation is headquartered in Calgary, Canada.

Leadership

Iris Bincovich

Chief Executive Officer & Interim Chair

Roni Kamhi

COO & Director

Nelson Harvey Halpern FCPA

Chief Financial Officer

Eyal Flom

Company Secretary, General Counsel & Independent Director

Employees

--

Country

CA

Sector

Healthcare

Website

innocanpharma.com

Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(0)
--
Insiderⓘ
(0)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Sources:
52-Week Range
$1.25$12.96
$1.29(0th percentile)
Volume
Average Daily Volume141
100 today vs 141 avg(-29%)

30d Avg

141

60d Avg

131

90d Avg

176

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...